Navigation Links
Early Pregnancy Test Reduces Down Syndrome in Children

Non-invasive screening of pregnant women with ultrasound early in pregnancy, combined with maternal blood analysis, has reduced the number of children born with Down Syndrome .

ng of pregnant women with ultrasound early in pregnancy, combined with maternal blood analysis, has reduced the number of children born in Denmark with Down Syndrome by 50%, a scientist will tell the annual conference of the European Society of Human Genetics today.

Professor Karen Brondum-Nielsen, of the Kennedy Institute, Glostrup, Denmark, will say that another benefit of the introduction of this procedure in her country was a drop in the number of invasive pre-natal diagnostic procedures from 11% to approx. 6% of pregnancies.

In September 2004, Professor Brondum-Nielsen will tell the conference, the National Board of Health in Denmark recommended new guidelines for prenatal diagnosis. Previously this was restricted to pregnant women over 35 years of age, but since the implementation of the new guidelines it has been available to any woman who wants it.

The women were offered a measurement of nuchal translucency in the fetus by ultrasound. This test looks at thickness of the black space (fluid) in the neck area of the fetus. If there is more than the normal amount of fluid the risk of Down syndrome is increased.

Likewise if there is a certain combination of serum markers in the maternal blood test, taken at the same time, there is the possibility of an increased risk of a chromosomal abnormality. The combined screening is carried out at 11 to 14 weeks of gestation.

Professor Brondum-Nielsen and her team looked at the effects of the new guidelines in 2004, 2005, and 2006, in 3 counties in Denmark with a total population of 1.1 million inhabitants, or about one-fifth of the population of the country.

They compared these findings with national figures obtained from the Central Cytogenetic Registry, which confirmed t
'"/>




Page: 1 2

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants

Post Your Comments:
(Date:12/2/2009)...ntists may not be able to tell a good book by its ...ld book by its smell. In a report in ACS, Analyti...ibe development of a new test that can measure the...documents based on their smell. The nondestructive...serve a range of prized paper-based objects, some ...
(Date:12/2/2009)...ampions Biotechnology, Inc. (OTC Bulletin Board: C...h a predictive preclinical platform aimed at accel... oncology drugs, has established an exclusive lice...Ltd., Tel Aviv University,s wholly owned technolog...ncompasses the development and commercialization o...
(Date:12/2/2009)... MyCareTeam, Inc., a leading vend...ftware, has released the newest version of its sof...rtension, congestive heart failure and weight mana...abetes monitoring features. , ...reTeam, Inc., a leading vendor of Internet-based c...
(Date:12/2/2009)... , ARLINGTON, Va., Dec. 2 Fro...life that give us meaning, joy and peace, the LIFE...ever contest conducted using the popular photo-sha...e viewed in a video montage on the LIFE Foundation.... ,, Contestants submitted one photo and a cap...
(Date:12/2/2009)... , MORRISTOWN, N.J., Dec. 2 /PRNewswire-FirstCa... today announced that the Federal Trade Commission...ublic comment relating to Watson,s pending acquisi... early termination of the Hart Scott Rodino waitin...the transaction. The parties have now obtained al...
Breaking Medicine News(10 mins):Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2
...POLIS, Dec. 8 A mural on a 1,230-foot-long wall,a...Indianapolis, has achieved,recognition as a new Gu...fication projects completed in partnership with Ke...ld last May. , Lilly and KIB submitted the m...
...LE, Calif., Dec. 8 Expresso Fitness(R), the leadi...tness systems, announced today,that it has complet...$14M.,The capital will be used to fuel Expresso,s ...xpresso. The equity round was,joined by all exist...
...EE, Dec. 8 Aurora Health Care and Associated Surg...premier ambulatory surgery centers, announced toda... the two organizations jointly operate the surgery...nce the quality of care for patients," said James ...
...rts are recommending that a malaria vaccine progre...l of the RTS, S/AS01E malaria vaccine among 5-17 m... Kenya, which is reported today in the New Englan...inistration of the RTS, S/AS02 malaria vaccine thr...
..., Dec. 8 Americans United for Life (AUL) condemns...e state have a right to die by assisted suicide, a...ontana State Supreme Court. , , Dr. Charmai...ses in Oregon where patients are denied state insu...
...ic Injury Protection Program Expands Benefits , ...s Affairs (VA) announced some severely injured mil...improvements to the Servicemembers, Group Life Ins...y personnel and their families," said Secretary of...
Other Medicine News:Health News:Lilly Global Day of Service Receives National and Local Recognition 2Health News:Lilly Global Day of Service Receives National and Local Recognition 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 2Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 3Health News:Expresso Fitness(R) Receives Additional $14 Million in Funding 4Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 2Health News:Promising trials of malaria vaccine lead to calls for Phase 3 development 3Health News:Americans United For Life Denounces Montana Court's Assisted Suicide Decision, Urges Appeal 2Health News:VA Announces Changes to Servicemembers' Group Life Insurance 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PR...a, including a late-breaking presentation on Tasig...chronic myeloid leukemia, demonstrate the strength...g the care of patients. ,, The new data, at th... Meeting and Exposition, highlight the company,s c...
(Date:12/1/2009)..., , NEW YORK, Dec . 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ... ,, http://www.reportlinker.com/p0164247/Insul..., Insulin pumps, also called Continuous Subcutan...ol over diabetes, when compared to other forms of ...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ...eview ,, http://www.reportlinker.com/p0164366....html ,, Over the years, Liquid Chromatography...ences, pharmaceuticals, food and beverage, researc...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Overweight kids experience more loneliness anxiety MU study finds 50660 1Overweight kids experience more loneliness anxiety MU study finds 50660 2Natural compound stops retinopathy 9106 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 2
...k Buyer for Marketed Parenteral Product Ganite(R),...ated,(Nasdaq: GNTA ) today announced that the Com...on covering novel pharmaceutical gallium compositi...ent Office. Issued U.S.,Patent 7,354,952 extends t... franchise of oral gallium-containing products tha...
...Developed and Validated Clinically at Clinical Lab...Laboratory at the University of Ca...cs Expects Three Tests Applying its MicroRNA Techn...ertified Labs During 2008, REHOVOT, Israel and JE... Ltd. (Nasdaq: ROSG ), a leader in,the development...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 2Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 4
Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: